Literature DB >> 820169

The enzymic defects in Morquio and Maroteaux-Lamy syndrome.

A Dorfman, B Arbogast, R Matalon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 820169     DOI： 10.1007/978-1-4684-7735-1_18

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  14 in total

1.  Coronary intimal sclerosis in Morquio's syndrome.

Authors:  S M Factor; L Biempica; S Goldfischer
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-08-04

Review 2.  Mucopolysaccharidosis IVA and glycosaminoglycans.

Authors:  Shaukat Khan; Carlos J Alméciga-Díaz; Kazuki Sawamoto; William G Mackenzie; Mary C Theroux; Christian Pizarro; Robert W Mason; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2016-11-29       Impact factor: 4.797

3.  Activity of daily living for Morquio A syndrome.

Authors:  Eriko Yasuda; Yasuyuki Suzuki; Tsutomu Shimada; Kazuki Sawamoto; William G Mackenzie; Mary C Theroux; Christian Pizarro; Li Xie; Freeman Miller; Tariq Rahman; Heidi H Kecskemethy; Kyoko Nagao; Thierry Morlet; Thomas H Shaffer; Yasutsugu Chinen; Hiromasa Yabe; Akemi Tanaka; Haruo Shintaku; Kenji E Orii; Koji O Orii; Robert W Mason; Adriana M Montaño; Toshiyuki Fukao; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2016-04-25       Impact factor: 4.797

4.  Mortality in patients with morquio syndrome a.

Authors:  Christine Lavery; Chris Hendriksz
Journal:  JIMD Rep       Date:  2014-04-10

Review 5.  Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.

Authors:  C J Hendriksz; P Harmatz; M Beck; S Jones; T Wood; R Lachman; C G Gravance; T Orii; S Tomatsu
Journal:  Mol Genet Metab       Date:  2013-04-10       Impact factor: 4.797

6.  Hematopoietic stem cell transplantation for Morquio A syndrome.

Authors:  Hiromasa Yabe; Akemi Tanaka; Yasutsugu Chinen; Shunichi Kato; Kazuki Sawamoto; Eriko Yasuda; Haruo Shintaku; Yasuyuki Suzuki; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2015-10-01       Impact factor: 4.797

7.  Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry.

Authors:  Shunji Tomatsu; Adriana M Montaño; Toshihiro Oguma; Vu Chi Dung; Hirotaka Oikawa; Talita Giacomet de Carvalho; María L Gutiérrez; Seiji Yamaguchi; Yasuyuki Suzuki; Masaru Fukushi; Kazuhiro Kida; Mitsuru Kubota; Luis Barrera; Tadao Orii
Journal:  J Inherit Metab Dis       Date:  2010-01-27       Impact factor: 4.982

Review 8.  Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA.

Authors:  Christian J Hendriksz; Maisoon Al-Jawad; Kenneth I Berger; Sara M Hawley; Rebecca Lawrence; Ciarán Mc Ardle; C Gail Summers; Elizabeth Wright; Elizabeth Braunlin
Journal:  J Inherit Metab Dis       Date:  2012-02-23       Impact factor: 4.982

9.  Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations.

Authors:  Shunji Tomatsu; Kazuki Sawamoto; Tsutomu Shimada; Michael B Bober; Francyne Kubaski; Eriko Yasuda; Robert W Mason; Shaukat Khan; Carlos J Alméciga-Díaz; Luis A Barrera; William G Mackenzie; Tadao Orii
Journal:  Expert Opin Orphan Drugs       Date:  2015-10-29       Impact factor: 0.694

10.  Clinical, radiologic, and genetic features of Korean patients with Mucopolysaccharidosis IVA.

Authors:  Na Hee Lee; Sung Yoon Cho; Se Hyun Maeng; Tae Yeon Jeon; Young Bae Sohn; Su Jin Kim; Hyung-Doo Park; Dong Kyu Jin
Journal:  Korean J Pediatr       Date:  2012-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.